IGFBP2 reprograms tumor microenvironment via IGF-independent integrin and nuclear pathways, driving therapy resistance.
Rewiring the tumor microenvironment: IGFBP2 at the Nexus of remodeling and therapy resistance?
Abstract
IGFBP2 reprograms the tumor microenvironment via IGF-independent integrin and nuclear pathways, driving therapy resistance and tumor aggressiveness.